5TQ3
Design and Synthesis of a pan-JAK kinase inhibitor clinical candidate (PF-06263276) suitable for the treatment of inflammatory diseases of the lungs and skin
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | APS BEAMLINE 21-ID-G |
Synchrotron site | APS |
Beamline | 21-ID-G |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2008-05-01 |
Detector | MARMOSAIC 300 mm CCD |
Wavelength(s) | 1 |
Spacegroup name | P 1 21 1 |
Unit cell lengths | 36.854, 182.726, 52.766 |
Unit cell angles | 90.00, 110.41, 90.00 |
Refinement procedure
Resolution | 34.540 - 2.690 |
R-factor | 0.21921 |
Rwork | 0.216 |
R-free | 0.27086 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 3tjc |
RMSD bond length | 0.011 |
RMSD bond angle | 1.571 |
Data reduction software | HKL-2000 |
Data scaling software | HKL-2000 |
Phasing software | PHASER |
Refinement software | REFMAC (5.8.0073) |
Data quality characteristics
Overall | |
Low resolution limit [Å] | 40.000 |
High resolution limit [Å] | 2.690 |
Rmerge | 0.120 |
Number of reflections | 16600 |
<I/σ(I)> | 11.9 |
Completeness [%] | 92.0 |
Redundancy | 2.5 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 7.5 | 293 | 0.1 M Hepes, pH 7.5, 0.1 M Sodium acetate, 30% PEG3350 |